Skip to content

Study on Cemented Versus Non-cemented Hemiarthroplasty in Elderly With Hip Fractures

A Prospective Randomized Multicenter Study on Cemented and Non-cemented Hemiprosthesis in Older Patients With Dislocated Hip Fracture.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00800124
Acronym
CNC
Enrollment
334
Registered
2008-12-01
Start date
2005-06-30
Completion date
2011-06-30
Last updated
2014-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fracture

Keywords

hip fracture, hemiprosthesis, bone cement, clinical outcome

Brief summary

The objective is to study the overall frequency and cumulative rate (during one year) of clinical morbidity (defined as any hospitalization without fatal outcome) and mortality in all consecutive patients undergoing HF surgery (pins and prosthetic implants) and compare this to the group of patients receiving prosthetic implants and further find out if there is a difference between the non-cemented and cemented groups. Between the same prosthetic groups, the investigators want to study the overall frequency of in-hospital subclinical organ damage and dysfunction of myocardium, liver and lungs, using biochemical plasma markers. Finally, the investigators want to perform perioperative cost benefit calculations and out of hospital quality of life analysis between the surgical groups.

Interventions

PROCEDUREcemented Landos prosthesis vs. uncemented Landos prosthesis

randomization between the cemented and non-cemented prosthesis.

Sponsors

Rikshospitalet University Hospital
CollaboratorOTHER
Sykehuset Buskerud HF
CollaboratorOTHER
Sykehuset Innlandet HF
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with Garden 3 or 4 fracture in acute hip fractures. * Age over 75 years.

Exclusion criteria

* Patient or relative refuse enrollment

Design outcomes

Primary

MeasureTime frame
Mortality1 year after surgery

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026